L
Lablite
Optimising clinical care strategies and laboratory monitoring for cost-effective roll-out of antiretroviral therapy in Africa: the Lablite project
LATA
Long-Acting Treatment in Adolescents (LATA): A randomised, open-label, two-arm, 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in sub-Saharan Africa
Leg Ulcers: Bandage comparison, systematic review and IPD meta-analysis
Four-layer compression bandage compared with short stretch bandage for venous leg ulcers: A systematic review and meta-analysis of randomised controlled trials of individual patient data
LU09
Three versus six courses of etoposide, cyclophosphamide, methotrexate and voncristine versus six courses of etoposide and ifosfamide in small cell lung cancer
LU10
A phase II trial of alternating chemotherapy and radiotherapy in small cell lung cancer
LU11
A randomised trial of post-operative radiotherapy in non-small cell lung cancer
LU12
A randomised trial of 4-drug vs less intensive 2-drug chemotherapy in the palliative treatment of patients with non-small cell lung cancer and a poor prognosis
LU13
A randomised trial of palliative 2-fraction vs more intensive 13-fraction radiotherapy for patients with inoperable NSCLC and a good performance status
LU14
Adding GCSF (lenograstim) to chemotherapy to try and increase the dose intensity of chemotherapy given to patients with small cell lung cancer
LU15
Adding GCSF (filgrastim) to chemotherapy to try and increase the dose intensity of chemotherapy given to patients with small cell lung cancer
LU16
A randomised trial of oral etoposide vs intravenous multi-drug chemotherapy in the palliative treatment of patients with small cell lung cancer and a poor prognosis
LU17
A randomised trial of supportive treatment with or without immediate thoracic radiotherapy in the prevention and palliation of symptoms in patients with inoperable non-small cell lung cancer and minimal thoracic symptoms
LU18
A randomised controlled clinical trial of endobronchial treatment versus external beam radiotherapy in the management of endotracheal or endobronchial obstruction by lung cancer
LU19
A randomised controlled intensification clinical trial of chemotherapy with or without recombinant human granulocyte colony stimulating factor (G-CSF) in small-cell lung cancer
LU20
A randomised trial of neo-adjuvant chemotherapy followed by resection versus radiotherapy in patients with T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer (NSCLC)
LU21
A randomised clinical trial of isosfamide, carboplatin and etoposide with mid-cycle vincristine (ICE-V) versus standard practice chemotherapy in patient with small-cell lung cancer (SCLC) and good performance status
LU22
Surgical resection with or without pre-operative chemotherapy in patients with operable non-small cell lung cancer
Lung cancer: preoperative chemotherapy, systematic review and IPD meta-analysis
Preoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual participant data
Lung cancer: chemotherapy, surgery, radiotherapy, two systematic reviews and IPD meta-analyses
Adjuvant chemotherapy and surgery (with or without radiotherapy) versus surgery (with or without radiotherapy) for non-small cell lung cancer: Two systematic reviews and meta-analyses of individual patient data
Lung cancer: chemotherapy and supportive care, a systematic review and IPD meta-analysis
Chemotherapy and supportive care versus supportive care for advanced non-small cell lung cancer: A systematic review and meta-analysis of individual patient data
Lung cancer: TKI inhibitors, systematic review and aggregate data meta-analysis
Should tyrosine kinase inhibitors be considered for advanced non-small cell lung cancer with wild type EGFR? Two systematic reviews and meta-analyses of randomised trials
Lung cancer: post-operative radiotherapy, a systematic review and IPD meta-analysis
Postoperative radiotherapy for nonāsmall cell lung cancer
LY06
A multicentre evaluation of National Cancer Institute protocol 89-C-41 (with minor modifications) in Burkitt or Burkitt-like non-Hodgkin lymphoma
LY09
A randomised trial of therapy for advanced Hodgkin lymphoma